
|Articles|September 13, 2021
Pharmacy Clinical Pearl of the Day: Crohn Disease
Author(s)Saro Arakelians, PharmD
Crohn disease causes inflammation of the digestive tract, which can lead to abdominal pain, severe diarrhea, fatigue, weight loss, and malnutrition.
Advertisement
Clinical Pearl of the Day: Crohn Disease
Crohn disease is a type of inflammatory bowel disease.
Explanation
- Crohn disease causes inflammation of the digestive tract, which can lead to abdominal pain, severe diarrhea, fatigue, weight loss, and malnutrition.
- Symptoms include diarrhea, fever, fatigue, abdominal pain, cramping, blood in the stool, mouth sores, reduced appetite, and weight loss.
- The condition could be genetic or caused by an immune system reaction.
- Risk factors include age, ethnicity, family history, cigarette smoking, and non-steroidal anti-inflammatory drugs.
- Treatment includes anti-inflammatory drugs, such as corticosteroids and oral 5-aminosalicylates; immune system suppressors such as azathioprine and methotrexate; biologics such as Remicade, Tysarbi and Stelara; antibiotics such as Cipro and Flagyl; and anti-diarrheal medications, pain relievers, vitamins, and nutrition therapy.
References
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Study: Many Patients Switching Biologics Because of Perceived Lack of Efficacy Treating Asthma
2
ADCs in Breast Cancer: Shaping the Future of HER2– and TROP2-Targeted Therapy
3
FDA Approves Targeted Combination Therapy for BRCA2-Mutated Prostate Cancer
4
Targeted ADCs Break Through Barriers in HER2-Positive Breast Cancer
5

















































































































































































































